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Sleep and its disorders are increasingly becoming important in our sleep deprived society. Sleep is intricately connected to various
hormonal and metabolic processes in the body and is important in maintaining metabolic homeostasis. Research shows that sleep
deprivation andsleep disordersmay have profoundmetabolicand cardiovascular implications. Sleep deprivation, sleep disordered
breathing, and circadian misalignment are believed to cause metabolic dysregulation through myriad pathways involving
sympathetic overstimulation, hormonal imbalance, and subclinical inﬂammation. This paper reviews sleep and metabolism, and
how sleep deprivation and sleep disorders may be altering human metabolism.
1.Introduction
Consequences of sleep deprivation and fragmentation are
beingincreasinglyrecognized.Weareasleepdeprivedsociety
with evidence showing that we sleep on an average 6.8 hours
as opposed to 9 hours a century ago. Around 30% of adults
report sleeping less than 6 hours per night [1–3]. The 24/7
economyand its subsequentimpact onsleep patterns may be
testingthebodieslimitstomaintainmetabolicandhormonal
equilibrium. Prevalence of both diabetes and obesity has
increased to acquire pandemic proportions. Though other
factors such as diet and reduced physical activity have
contributed to the obesity epidemic the impact of sleep
dysregulation on causing metabolic derangements is being
increasingly recognized. Considering only a small percentage
of people can maintain a healthy weight over a long period
on diet and exercise alone, the impact of sleep on weight has
opened a new venue for potential intervention.
Understanding this topic is important as both sleep and
metabolicdysregulationarecommonandgrowingproblems.
There are many unresolved issues including cause and eﬀect,
pathogenesis and potential implications to therapy.
2.MetabolisminNormalSleep
Human sleep comprises of nonrapid eye movement sleep
(NREM) and REM sleep. NREM is further comprised of
three stages (stages N1, N2, and N3). N3, also referred to as
slow wave sleep, is considered deep sleep with the body being
least metabolically active during this period. REM sleep is
characterized by vivid dreams, loss of muscle tone, and
rapid eye movements. The EEG pattern of REM sleep closely
mimics that of wakefulness marked by a high-frequency
and low-voltage wave pattern. NREM and REM sleep occur
alternatively in cycles of around 90 minutes throughout the
night [4]. The ﬁrst half of the night is predominantly NREM,
and the second half is predominantly REM sleep. Sleep
architecture, though, is heavily inﬂuenced by genetic and
environmental factors including sex, race, socioeconomic
statusandcultureamongothers.Sleepdurationinmammals
generally depends on the size of the animal [5]. Elephants
require only 3 hours of sleep while rats and cats can spend
up to 18 hours in sleep. It is postulated that this may be due
to diﬀerences in metabolism. Smaller animals have higher
metabolic rate and higher body and brain temperatures
compared to larger animals.
Metabolism is deﬁned as the whole range of biochemical
processes that occur within a living organism. It constitutes
the two processes of anabolism (build up) and catabolism
(break down). In simpler terms, metabolism is the amount
of energy (calories) the body burns to maintain itself.
Metabolism in general is associated with cell injury due to
t h er e l e a s eo ff r e er a d i c a l s[ 6]. The lower metabolic rate and2 International Journal of Endocrinology
brain temperature occurring during non-REM sleep seem to
provide an opportunity to deal with the damage done during
awake and metabolically active period. Siegel and his group
from University of California at Los Angeles (UCLA) have
shown brain damage in sleep-deprived rats [7]. Most data
available and referred to in this review deals with glucose
utilization and energy expenditure.
It is believed that during normal sleep the metabolic
rate reduces by around 15% and reaches a minimum in the
morning in a standard circadian pattern [8, 9]. Only a 15%
reduction in metabolic rate appears counter-intuitive con-
sidering the prolonged state of physical inactivity. However,
the basal metabolic rate constitutes 80% of the metabolism
neededtomaintainallcellularprocessesinthebody.Glucose
utilization in normal subjects is highest during wakeful state
and lowest in NREM sleep and intermediate in REM sleep
[10].
Growth hormone and cortisol are two hormones that
have an impact on glucose regulation. Growth hormone
is typically elevated at onset of sleep with highest levels
during slow wave sleep (SWS) while cortisol levels are greatly
increased during the second half of the sleep, predominantly
in REM sleep [11, 12]. Studies on normal subjects with con-
stant glucose infusion during sleep (to suppress endogenous
glucose production) have revealed that a fall in brain glucose
metabolism contributed to a two-thirds fall in systemic
glucose utilization during sleep despite increase in glucose
and insulin levels. Reduced muscle tone and anti-insulin
like eﬀect of growth hormone surge during the ﬁrst half of
sleep contributes to the rest of fall in glucose utilization [13].
Hence there is a relative state of insulin resistance during
early phases of sleep.
During the latter part of sleep the glucose and insulin
levels fall despite continuous infusion of glucose. Other
studies have shown similar ﬁndings suggesting increased
glucose utilization during REM phase of the sleep and
increased glucose levels in the evening with reduced insulin
sensitivity [13]. In addition, studies have shown an increase
in cortisol levels in evening after just one night of sleep
deprivation contributes to glucose dysregulation [14].
3. Consequences of Sleep Deprivation
Although impact of sleep on glucose regulation has been
known and studied for some time, metabolic dysregulation
with sleep loss has only recently been understood. Prior
research models had focused on acute sleep deprivation.
Studies done by Hampton et al. revealed that when subjects
were made to simulate shift work it resulted in alterations
in postprandial glucose and lipid metabolism [15]. This
response was noted with 9-hour phase advance. The same
group later showed that it takes at least 2 days to adapt to
eating meals on a simulated night shift [16]. Since the body
has good rebound capacity, the metabolic derangements, if
any, were readily corrected in acute sleep loss model. The
more practical model to study is recurrent prolonged partial
sleep deprivation, which mirrors real life scenarios. In fact,
studies have shown that both slow wave sleep (SWS) and
growth hormone (GH) rebound after acute sleep loss, but no
s u c hs p i k ei ss e e ni nS W Sa n dG Hd u r i n gr e c u r r e n tp a r t i a l
sleep restriction [17, 18]. For these reasons, chronic sleep
deprivation models are more relevant in terms of clinical
signiﬁcance and subject of our focus.
Though a previous study has shown reduced insulin
sensitivity to oral glucose administration it was limited to
one night of sleep deprivation [19]. The ﬁrst detailed study
to examine the impact of partial sleep deprivation on glucose
tolerance was performed by Cauter et al. at the University
of Chicago. Eleven healthy young men were subjected to 4
hours in bed for 6 nights followed by 12 hours for 7 nights to
recover from sleep debt. Intravenous glucose tolerance test
was performed on the sixth day. Sleep deprivation resulted in
reducedglucosetolerance(rateofglucoseclearance)by40%.
Glucose eﬀectiveness, a measure of noninsulin dependent
glucose disposal, was 30% reduced along with a reduction in
insulin response to glucose [20]. A subsequent study with a
randomized crossover design by the same group conﬁrmed
the ﬁndings [21]. The conclusion from these laboratory
based studies is that a week of sleep deprivation can result in
a signiﬁcant alteration in metabolic and endocrine function.
The mechanism of sleep deprivation causing metabolic
dysregulation may be multifactorial. Changes in hormonal
secretionproﬁleasdiscussedabovemayhaveprofoundeﬀect
on glucose regulation [13].
Sympathetic stimulation has been shown to occur with
sleep deprivation [22] and might contribute in the metabolic
dysregulation. The third possible mechanism is inﬂamma-
tion. Experimental sleep deprivation has been found to alter
immune response and increase proinﬂammatory markers
such as IL-6, TNF-α , and CRP [23–25].
4.Sleep Durationand Risk of Diabetes
It is projected that by 2010, 221 million people would
be aﬀected by diabetes globally [26]. It is important we
understand the role of sleep in glucose metabolism and
potential directions for new research and therapy.
Epidemiological data increasingly suggests that short
sleep duration or chronic partial sleep deprivation may
increasetheriskoftypeIIdiabetes.Inalargecohortofnurses
(Nurse Health Study with more than 70,000 respondents),
self-reported short (5 hours or less) and long duration of
sleep (9 hours or more) was associated with symptomatic
diabetes with a relative risk of 1.34 for short [1.04–1.72])
and long 1.35 for long [1.04–1.75]) sleepers [27]. A Swedish
study with more than 2000 people followed for over 10
years revealed that short duration of sleep (<5h o u r s )a n d
diﬃculty initiating and maintaining sleep were associated
with higher incidence of diabetes in men (but not in
women) even after adjusting for confounding factors like
age, BMI, snoring, depression, and hypertension [28]. In
another study by Yaggi and colleagues, a large cohort of men
from the Massachusetts Male Aging Study (MMAS), without
diabetes at baseline was followed for more than 15 years in
a longitudinal study. Subjects who self-reported less than
6 hours of sleep were twice as likely to develop diabetes.International Journal of Endocrinology 3
Subjects sleeping longer than 8 hours were three times more
likely to develop diabetes. This elevated risk remained after
adjusting for HTN, age, waist circumference, smoking, and
education [29].
Although epidemiological studies do not establish
causality, these studies are consistent with the physiological
data discussed earlier.
In summary, the laboratory data seem to be supported
by large epidemiological studies (including longitudinal)
that short sleep duration might play an important role in
altering glucose metabolism. However, these results appear
to be more applicable to men than women for reasons not
fully understood. The relationship between increased sleep
duration and risk for diabetes is not fully understood.
5.SleepLoss andAppetite
5.1. Leptin and Ghrelin. The appetite center is believed to be
located in the arcuate nucleus of the hypothalamus, which
in turn is inﬂuenced and regulated by peripheral hormones
such as leptin and ghrelin. Leptin is an appetite suppressant
hormone produced by adipose tissue, and ghrelin is released
from the stomach primarily in response to fasting and
promotes the feeling of hunger [30]. Leptin has been shown
to rapidly increase or decrease in response to caloric shortage
orsurplus[31].Inhumanstudies,amarkedriseinleptinand
ghrelin are noted during sleep, though the levels of ghrelin
tend to fall during latter part of night despite maintenance
of fasting conditions [32, 33]. It is believed that leptin
levels stay elevated due to melatonin-inﬂuenced insulin-
triggered leptin production [34]. This suggests the eﬀects of
the rising ghrelin levels during the early part of night might
be blunted by leptin, preventing arousal during sleep due
to hunger. Spiegel and colleagues work on healthy humans
have also shown that sleep deprivation lowered leptin levels
by 19% compared to sleep extension [35]. They further
observed that sleep deprivation blunted the diurnal variation
normallyseenwithoutsleepdeprivation.Theseﬁndingswere
conﬁrmed by the same group in a randomized crossover
trial of sleep restriction in normal human subjects. Subjects
were sleep restricted for 2 nights (4 hours/night) followed
by 2 nights of sleep compensation (10 hours/night) while
receiving continuous glucose infusion. Signiﬁcant reduction
in leptin levels (18%) were noted with a concomitant 28%
increase in ghrelin levels [36]. A 24% increase in hunger
rating and 23% increase in appetite rating were also noted.
Reduction of leptin level was a signiﬁcant predictor of
magnitude of hunger observed. Further analysis of appetite
rating revealed that subjects tended to show more preference
to high carbohydrate foods (sweets, salty food and starchy
foods), that is, Craving for salty food increased by 45%
(P = .02). This suggests that sleep deprivation may aﬀect
eating behavior favoring nonhomeostatic food intake (food
intake driven by emotional/psychological need rather than
caloric need of the body) [36]. Acute sleep deprivation of
single night in young healthy men increases ghrelin levels
but not leptin levels [37]. Sleep deprivation may also aﬀect
the circadian proﬁle of leptin. Healthy men subjected to
88 hours of sustained wakefulness have been shown to
have reduced diurnal amplitude of leptin, with return to
normal rhythm on sleep recovery [38]. Recent study by
Penev et al. revealed that short, partial sleep deprivation
(<5.5 hours/day) in normal subjects resulted in increased
consumption of calories from snacks but no increase in total
energyconsumption. This study did not show anysigniﬁcant
changes in leptin or ghrelin levels. The authors hypothesized
that the higher carbohydrate intake due to sleep restriction
may be due to prolonged exposure to more palatable food
[39].
A population based study of 1024 patients (derived
from the Wisconsin sleep cohort study, a large longitudinal
population based study on sleep disorders) that revealed
similar alteration in leptin and ghrelin levels based on total
sleep time as measured by overnight polysomnography [40].
The study also revealed that chronic sleep deprivation (sleep
less than 8 hours) was associated with increase in BMI.
Leptin has been found to be elevated in obese individuals
and patients with obstructive sleep apnea. It is believed that
theelevatedCRPlevelsinobesityandobstructivesleepapnea
bind to leptin resulting in elevated serum levels [41]. This is
believedtobeaccompaniedbyleptinresistanceduetodown-
regulation of leptin receptors. This leads to impairment in
weight regulation and may contribute to weight gain [42].
The fact that relationship between sleep and leptin may
be bidirectional is evident by animal studies by Laposky et
al. Leptin deﬁcient mice have been shown to have more
disrupted sleep architecture, increased time spent in NREM
sleep and increased total sleep time [43] .T h es a m ea u t h o r s
also showed that leptin signaling exerts a role in sleep-
wake regulation. Obese/diabetic mouse with mutation of
leptin receptors exhibited sleep fragmentation, decreased
compensatory response to sleep deprivation and decrease
locomotor response [44].
In summary, leptin may represent an important link
between, sleep, circadian rhythm and metabolism.
5.2. Orexins. D i s c o v e r yo fe x c i t a t o r yn e u r o p e p t i d eh o r -
mones orexins A and B (hypocretins) expressed from
neurons located in perifornical region of the hypothalamus,
[45] has signiﬁcantly added to our knowledge. Energy
homeostasis, as determined by the balance between calorie
intake and energy expenditure, is regulated by hypothalamus
[46]. Orexins neurons are located in the hypothalamus
and from them project throughout the brain, including
paraventricular nucleus of the thalamus, the arcuate nucleus
and, most notably, the locus coeruleus, dorsal, and tubero-
mammillary nucleus (areas involved in wakefulness) but not
the cerebellum [47, 48]. Orexins have been found to be
inﬂuenced by peripheral metabolic cues like leptin, ghrelin,
and glucose which indicated that orexins may provide an
important link between sleep and metabolism [49]a n d
play a key role in metabolism. Administration of orexins
increases food intake and stimulates wakefulness and energy
expenditure [50, 51]. Narcolepsy, a sleep disorder caused
by orexin deﬁciency is accompanied by decreased energy
intake, increased BMI, and increased incidence of type 24 International Journal of Endocrinology
diabetes [52, 53]. Orexin knockout mice also demonstrate
late onset weight gain [54]. The fact that orexin deﬁcient
mice display reduced energy expenditure independent of
sleep duration and wake durations suggests that orexin-
induced increased metabolism is not simply due to its wake
promoting action and subsequent more exposure to food
[55]. Recently investigators, working on glucose metabolism
in orexin knockout mice, found that orexin is essential for
maintenance of normal insulin sensitivity with increasing
age [56]. In conclusion, these ﬁndings suggest that sleep
deprivation may blunt and upset the ﬁnely tuned signaling
response of hormones to body’s caloric needs not only
leading to increase in appetite but also a propensity for
psychological eating (nonhomeostatic food intake).
6.Slee pDe pri vatio nandW e ight
More than two dozen epidemiological studies from around
the globe looking at sleep deprivation and BMI in humans
have shown association between decreased obesity and an
increase in sleep duration. These studies however do not
establish a causal relationship. Few studies revealed a U-
shaped curve with lowest mean BMI associated with 7.7
hours/night [40, 57, 58]. NHANES study revealed (using a
normal benchmark of 7 hours/night) odds ratio for obesity
as 2.35 for 2–4 hours/night, 1.60 for 5 hours/night, and 1.27
for 6 hours/night of sleep. This association was observed in
both obese and nonobese subjects and adjustment for sex,
age, and population size though the relationship appeared to
wane with age [40, 57, 59–62]. These ﬁndings are supported
by studies conducted in children [63–65]. The impact of
short sleep appeared to be greatest in children and young
adults as compared to older adults [61–69].
A major limitation of epidemiological studies looking at
sleep duration and BMI has been self-reporting of sleep time
as opposed to objective measurement. However recent stud-
ies [56, 70–72] have looked at objectively measuring sleep via
actigraphy (device worn like a watch with ability to record
gross motor movements) and overnight polysomnography.
The CARDIA study [70] used a large cohort of subjects and
obtained 3 nights of actigraphy. Mean sleep duration was
foundtobe6.1hourswithvariationamongdiﬀerentrace-sex
groups (mean sleep duration of 6.7 hours in white females
to 5.1 hours in African-American males). This study also
foundmoderatecorrelationbetweensubjectiveandobjective
sleep time duration though participants overreported their
sleep duration by about 0.8 hours (measured sleep duration
was 6 hours versus a self-reported time of 6.8 hours). The
Danishrevealedthatsleepinglessthan5hourswasassociated
with higher BMI in elderly population. Sleep fragmentation
was also found to be strongly associated with increased
BMI in this study [71]. In another recent study with over
3000 patients where the sleep duration was again objectively
recordedbyactigraphy,researchersfoundthatoldermenand
women with reduced amounts of sleep (less than 5 hours) as
measured by actigraphy had an elevated BMI. Sleeping 5 or
fewer hours per night was associated with 3.7-fold greater
odds of obesity among men and 2.3-fold increase among
women compared to those sleeping 7-8 hours per night Patel
etal.[73].Apartfromcrosssectionalstudies,therehavebeen
9prospective/longitudinalstudiesinadultsandchildren,8of
which have shown similar ﬁndings of sleep deprivation and a
higher prevalence of obesity [61, 62, 65, 74–76].
Data regarding impact of sleep deprivation on weight
loss is conﬂicting in animals and humans. Sleep deprivation
in rodent models causes weight loss despite hyperphagia
[63–68]. These diﬀerences in rodents and humans may be
explained by increased brown fat in rodents (rarely present
in adult humans), which is metabolically more active and
has been shown to increase thermogenesis and total energy
expenditure [67]. In conclusion, epidemiological data is
suggestive of weight gain with sleep deprivation though a
fewstudieshavealsonotedweightgainwithprolongedsleep.
Based on data on sleep duration and weight, sleep hygiene
counseling could form an important tool in management of
obesity.
7.ObstructiveSleepApneaandTypeIIDiabetes
Obstructive sleep apnea (OSA) is a highly prevalent disorder
aﬀecting 2%–4% of the population. It is characterized by
intermittent but repetitive cessation of breathing accompa-
nied by hypoxemia or reduced level of oxygen in blood. OSA
has signiﬁcant aﬀect on sleep architecture including sleep
fragmentation and reduction in stage REM and slow wave
sleep (SWS) [77].
Data from a recent national survey shows that as many as
one in four adults are at risk of having OSA [78]. More than
50% of patients with type II diabetes have obstructive sleep
apnea [79]. Studies as early as 1985 had noted an association
between snoring, diabetes, and abnormal glucose tolerance
[80, 81]. A Swedish study with longitudinal design and over
2600 subjects revealed habitual snoring as an independent
risk factor for diabetes at 10 year followup [82]. Several
studies since then have supported the ﬁndings of snoring
associated with increased prevalence of type II diabetes, with
habitual snorers being at twice the risk for having diabetes
[83, 84].
Cross-sectional studies using polysomnography con-
ﬁrmed OSA have similarly shown increased insulin resis-
tance, glucose intolerance and an increase in HgA1C [85–
88]. Importantly, the severity of OSA appears to be pro-
portional to the severity of metabolic dysfunction. This
association stood after adjustment to age, sex, and adiposity.
However, a longitudinal study by Wisconsin sleep cohort
group failed to show an independent relationship between
OSA and incidence of diabetes at 4-year followup. These
conﬂicting results may be due to short duration of the study
[89].
Clinic-based studies have demonstrated similar trends
favoring an association between OSA and diabetes. In a
study of patients with OSA compared to obese patients
without OSA were found to have higher fasting glucose,
higher insulin levels, and higher systemic inﬂammatory
markers [90]. In a subsequent larger study by Punjabi and
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underwent polysomnography, oral glucose tolerance test,
and determination of body fat. In this study, the prevalence
of OSA (deﬁned as AHI > 10/hrour) was more than 45%.
After adjusting for BMI, OSA was associated with increased
risk of having impaired glucose tolerance (Odds ratio of
2.15) and related to degree of oxygen desaturation [85].
Studies on a large Asian cohort done by Ip et al. also found
OSA to be independently associated with insulin resistance
as measured by HOMA-IR (homeostasis model assessment
of insulin resistance) [86]. Similarly a large European study
(595 patients) revealed that type II diabetes was present
in 30% of patients with OSA [91] and a Japanese study
(213 patients) found increased insulin resistance in patients
with OSA [92]. Though most studies looked at BMI, few
studieslookedatvisceralobesityandwaisttohipratio,which
more closely relates to insulin resistance than BMI [92, 93].
Though most studies have supported an association between
OSA and diabetes/glucose dysregulation, a few studies have
been negative [94, 95]. This is not surprising as obesity is
a huge confounding factor in all studies dealing with OSA.
These data simply indicate an association between OSA and
type II diabetes and does not however establish causality or
direction of causality.
If it is true that OSA causes diabetes, then treatment of
OSA should mitigate the metabolic dysregulation. However,
treatment by CPAP (continuous positive airway pressure
therapy), which is currently the most accepted therapeutic
intervention for OSA has shown inconsistent results. Several
studies have shown improvement in insulin sensitivity after
varying periods of CPAP therapy in patients with diabetics
and nondiabetics [96–98], including a study showing a
reduction in HbA1C [99]. A German study using the
hyperinsulinemic euglycemic clamp technique (the gold
standard for measuring insulin sensitivity) evaluated 40
patients with moderate to severe obstructive sleep apnea
and found improved insulin sensitivity after only 2 days of
CPAP therapy, which persisted during a 3 month followup
[100]. This rapid improvement suggests that the resolution
of sympathetic drive might play an important role in the
pathogenesisofmetabolicdysregulationseeninpatientswith
obstructive sleep apnea. However, the debate on the impact
of CPAP therapy in mitigating metabolic dysregulation is
far from resolved. Equal numbers of studies have shown
no impact of therapy on diabetes or glucose metabolism
[101–104]. A uniform problem with these studies has been
small number of patients and no controls. Recently, two
randomized controlled trials have been conducted. A study
by Coughlin et al. took 34 patients with severe sleep apnea
and metabolic syndrome and randomized them to receive
CPAP therapy versus sham CPAP followed by a crossover
after 6 weeks. The study failed to show any improvement in
insulin sensitivity or metabolic proﬁle despite improvement
in blood pressure [105]. West et al. evaluated 42 patients
with OSA and diabetes and randomized them to 3 months
of treatment versus sham treatment. The study did not show
any signiﬁcant improvement in glycosylated hemoglobin
or insulin resistance measured by euglycemic clamp and
HOMA [106]. The compliance in this study was however
suboptimal (3.6 hours/night) and may have aﬀected the
outcome. Whether this had any impact is debatable. One
major confounding factor in these studies is obesity. Harsh
and colleagues showed that the improvement in insulin
sensitivity in patients with BMI > 30kg/m2 is minimal
[100] but improved after 3 months [107]. Future studies are
required to deﬁne the correct patient proﬁle, time duration
and impact of compliance, to get better understanding of the
role of CPAP therapy in improving diabetes.
It is believed that obstructive sleep apnea may cause
metabolic dysregulation through several pathways. Sympa-
thetic surge is known to occur with each apnea event.
Sympathetic activation has been shown to increase levels
of circulating free fatty acids because of the stimulation of
lipolysis, which promotes insulin resistance [86]. Elevated
catecholamine levels were found in people with more wake
time after sleep onset [108]. Additionally, sleep fragmenta-
tion, recurrent hypoxemia, and triggering of inﬂammatory
cytokines on a nightly basis may all contribute to higher
propensity to metabolic syndrome and type II diabetes.
The relative contribution of any of the above pathways
is not known. Some of these pathways may overlap with
suggested pathophysiological pathways of sleep deprivation
and circadian misalignment (Figure 1).
In summary while there is growing evidence of an
association between OSA and metabolic dysregulation the
direction of causality and decoupling of major confounding
factor of adiposity has not been clearly stated. Data on
interventional studies is also conﬂicting and marred by small
sample sizes, inadequate power, and observational design.
8. Metabolic Consequences of
Shift Work Disorder
Sleep is controlled by two powerful processes: circadian and
homeostatic [109]. During waking hours, the sleep drive
gradually increases until it reaches a critical threshold. This
drive is referred to as homeostatic. Circadian rhythm, on
the other hand, is a signal generated by the master clock,
the suprachiasmatic nucleus (SCN) located in the anterior
hypothalamus. Circadian rhythm, derived from the Latin
term “circa diem” which literally means “approximately one
day” is the body’s internal clock. This clock is set at slightly
over 24 hours. It controls sleep as well as most biological
processes, including hormone production, metabolism, core
body temperature variations, and cell regeneration among
others [110]. This clock is normally highly synchronized to
environmental cues (Zeitgebers, German for “time giver”),
the strongest of them being the light-dark cycle. In most
humans the alertness pattern shows a biphasic distribution,
with a mid-day decrease in alertness around 2–4pm, fol-
lowed by an increased alertness during mid to late evening,
and ﬁnally declining to its lowest levels during the night
[109, 111]. Almost all physiological systems in humans run
slightly over a 24 hour cycle. Disturbance of this well-
regulated circadian rhythm and homeostatic drive (circadian
misalignment)canleadtovarioussleepdisorderscollectively
known as circadian rhythm sleep disorders. Shift work
disorder is one of the circadian rhythm disorders which have6 International Journal of Endocrinology
Circadian
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Hormonal changes
Obesity
Figure 1: Schematic diagram of potential mechanism of glucose dysregulation/diabetes pathogenesis, secondary to sleep loss, sleep apnea,
and circadian misalignment. The three main sleep disorders are listed at the top. Arrows point to possible pathophysiological alteration the
disordersmayinduce.Someofthepathwaysarecommontoallthedisordersandarelistedtogether,thatis,sympatheticdrive,inﬂammation,
and alteration of HPA axis. Sleep loss may in addition lead to changes like hormonal imbalance and reduced activity (listed on the box to
the right of the diagram). Similarly circadian alteration may also cause insulin resistance and hormonal imbalance (shown in the box to the
left). All these pathophysiological alterations eventually may lead to type II diabetes which is shown in the center. SWD: Shift work disorder.
been a focus of large epidemiological studies for its potential
implications on health.
Peopleinvolvedinsomeformofshiftworkareincreasing
globally. U.S. Bureau of Labor statistics indicate that 8.6
millionpeoplewereshiftworkersin2004intheUnitedStates
alone [112]. Circadian misalignment due to shift work or jet
lag has been associated with obesity, diabetes, and cardio-
vascular diseases. A Swedish study followed shift workers for
15 years and reported increased relative risk for ischemic
heart disease (RR = 2.8) as compared to daytime workers
independent of smoking and age with similar socioeconomic
background [113]. More recent studies have suggested that
shift work is the most signiﬁcant source of ischemic heart
disease accounting for over 10% of mortality in men and
over 5% in women [114]. Another prospective study found
increased risk of circulatory diseases in shift workers after
controlling for confounding factors [115]. In a large cohort
of subjects followed prospectively in the Nurse Health Study
II investigators found increased risk of type II diabetes in
young and middle age nurses working in rotating night
shift work [116]. Cross-sectional data also suggests higher
triglyceride levels, lower HDL levels, and more obesity
in the shift workers than daytime workers [117, 118].
Anotherrecentstudyemulatingshiftworkforshortduration
(10 days) revealed decreased leptin, increased glucose, and
reversed cortisol rhythm. Circadian misalignment caused 3
of the 8 subjects to exhibit postprandial glucose responses in
the range typical of a prediabetic state [119].
Mechanistic pathways by which shift work can cause
metabolic dysregulation are not clear but appear to involve
hormonal alterations and increased sympathetic drive lead-
ing to decreased insulin sensitivity and insuﬃcient beta-cell
compensation.Possibilityofalteredmelatoninproﬁleduring
circadian misalignment contributing is another potential
pathwayasthereissomeevidencethatmelatoninmayinhibit
glucose-induced insulin release [120]. Additionally, animal
models subjected to circadian alterations simulating shift-
work have resulted in premature death [121].
In conclusion, the limited data regarding circadian
misalignment suggests its role, albeit unclear, in metabolic
dysregulation. Since sleep deprivation is commonly asso-
ciated with shift work disorder further prospective trials
adjusting for sleep deprivation are required to establish role
of circadian misalignment as opposed to indirect eﬀect of
sleep deprivation on metabolic dysregulation.
9.EnergyExpenditurein
Sleep andSleepDisorders
Severalstudieshavelookedattherelationshipofbodyenergy
expenditure in sleep and sleep disorders (mainly OSA). TheInternational Journal of Endocrinology 7
energy expenditure of human body appears to reduce and
is lowest during sleep [122–125]. This reduction in energy
expenditure may be inﬂuenced by circadian rhythm [122,
126], changes in body temperature [127], and reduction in
muscle activity [128, 129], not to mention the depth and
duration of sleep and physical activity [8, 129–132]. Energy
expenditure has also been reported to vary depending on
the stage of sleep [8, 133]. Race also seems to play a role as
African-Americans appear to have a lower sleep metabolic
rate (SMR) and increased propensity for weight gain as
compared to Caucasians [134]. Also SMR decreases during
sleep as a function of BMI and the decrease rate in SMR is
larger as BMI increases [134].
Acute sleep loss results in small increase in SMR [122,
133, 134]. A similarly small increase in SMR has been
recorded in chronic sleep deprivation [135].
Limited studies looking at energy expenditure in patients
with obstructive sleep apnea have revealed mixed results.
Stenlof et al. found higher total energy expenditure (TEE)
and SMR with reduction in energy expenditure upon
treatmentwithcontinuouspositivepressuretherapy(CPAP).
A study by Lin et al. found increase in SMR but not morning
BMR in patients with OSA. Patients in this study who
underwent laser-assisted uvulopalatoplasty demonstrated a
reduction in SMR. However, Hins et al. found no relation-
ship between OSA and TEE or SMR. Similar mixed results
have been noted in children [136–138].
In summary, energy expenditure is reduced during sleep.
Sleep deprivation appears to increase energy expenditure.
Data in impact of sleep apnea on energy expenditure is
equivocal. Studies in patients with OSA are also limited
by small size and lack of body composition data which
signiﬁcantly impacts energy expenditure. It is also important
to point out that most of these studies have utilized indirect
calorimetrytechniqueinsteadofthegoldstandardmetabolic
chamber (direct calorimetry). Larger studies utilizing direct
calorimetric techniques are needed to understand the impact
of sleep apnea on energy expenditure.
10. Conclusions
Sleep disorders and diabetes are rapidly growing problems
with grave public health implications. There is growing
interest and evidence that sleep loss and sleep disorders
have a signiﬁcant impact on metabolism. Laboratory studies
have clearly shown that sleep deprivation can alter the
glucose metabolism and hormones involved in regulating
metabolism, that is, decreased leptin levels and increased
ghrelin levels. A majority of large epidemiological studies
have suggested that chronic partial sleep deprivation is
associated with an increased risk of obesity and diabetes.
However, there are several areas where the data conﬂicts. The
role of gender is not entirely clear. Ayas et al. and Mallon
et al. have shown that while sleep duration does predict
diabetes in women, the signiﬁcance is lost once corrected
for risk factors like BMI. The relationship of sleep duration
to metabolic dysregulation is also found to be U-shaped in
many studies (nurse health study, sleep heart health study,
and Massachusetts male health study) suggesting that not
only short duration but also longer duration may have the
potential to disturb the metabolic equilibrium of the body.
Paradoxically a similar U-shaped relation is also noted in
several studies looking at the relationship between sleep and
weight, with both short and long sleep leading to weight
gain [62, 139]. Most epidemiological studies have relied on
subjective self-reported measures of sleep duration.
Further studies are needed to clearly elucidate the role of
gender, sleep duration, and metabolism with more objective
measurements of sleep. Also needing to be clariﬁed is the
diﬀerence between sleep deprivations due to voluntary sleep
loss versus Insomnia. A model of nonobese patients with
OSA may help decouple the impact of adiposity on diabetes.
Diﬀerences exist between human and animal response to
sleep deprivation on weight. Mechanism explaining the
complex interaction between sleep and metabolism need to
befurtherexploredifwehopetoderivemoreclinicalmileage
with sleep becoming an important tool to ﬁght the obesity
pandemic.
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